Wall Street believes the biopharma's focus on developing treatments for rare neuromuscular diseases is paying off. » Read More
By: Tae Kim
Credit Suisse believes Pfizer will suffer from the patent expirations of its key drugs such as Viagra and Lyrica. » Read More
Cardinal Health has put its China business up for sale, drawing keen interest from state-backed Chinese pharmaceutical firms. » Read More
By: Luke Graham
Presidents Trump and Obama made the same mistake, a former U.S. assistant secretary of Commerce tells CNBC. » Read More
Intel has eliminated its wearables product group, a source tells CNBC.
Jim Cramer broke down his strategy to why Snap fell out of his favor.
Collaborative relationships with hospitals across the globe are improving patient outcomes and operational efficiencies.
Obamacare won't collapse under its own weight — if it is done in, it will be because of Republicans, Mario Molina said.
The news comes after President Donald Trump pushed Republican senators to reach an agreement on a measure before the August recess.
The GOP health bill failure will hurt Republicans in Congress more than it will touch President Trump, says Jake Novak.
Despite reports of a “death spiral,” Obamacare is alive and well in many states. But the White House could try to weaken it.
As bad headlines fade and Vertex rises, biotechnology is on the upswing, says Jefferies' Michael Yee.
McConnell said Senate vote on a motion next week to move ahead with a bill to repeal and or replace Obamacare could easily be amended.
On health care, Trump is uninformed, underprepared, and unclear — and this is is the result, Vox reports.
Medical marijuana still faces many hurdles in the U.S. There's an even bigger market that is ripe for investment, says CEO Benjamin Ward.
He said Republicans had promised Americans they would repeal and replace Obamacare for seven years and that now is the time to act.
Shkreli is accused of using sham settlement and consulting agreements from his drug company to pay off investors he allegedly defrauded.
An experiment from an Alphabet subsidiary begins today in Fresno designed to reduce the local mosquito population, The Verge reports.
The ongoing battle for Charlie Gard's treatment has taken a new turn.
A new report found cities' stress levels are influenced by poverty and divorce rates, U.S. News reports.
Get the best of CNBC in your inbox